Related Experiment Video
Updated: Oct 13, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Peritoneal metastases from malignant degeneration of ectopic gastric epithelium in Meckel's diverticulum: A case
Ehab El Bahesh1, Bruce M Abell2, Paul H Sugarbaker3
1Division of Hematology and Oncology, George Washington University Cancer Center, Washington DC, USA.
Background:
Meckel's diverticulum is the most common congenital anomaly of the gastrointestinal tract, resulting from incomplete obliteration of the omphalomesenteric duct in early fetal development. The diverticulum frequently contains ectopic gastrointestinal epithelial tissue, most commonly gastric or pancreatic. Adenocarcinoma can arise from either of these epithelia but is extremely rare, with less than 50 cases reported in the world literature.
Methods:
In a patient with peritoneal metastases from ectopic gastric mucosae in a Meckel's diverticulum a multidisciplinary treatment plan was initiated.
Results:
Diagnosis was evident from study of the resected specimen of small bowel in a patient with acute abdominal pain. A multiagent chemotherapy regimen using oxaliplatin, mitomycin C, doxorubicin, and capecitabine (O-Max) resulted in a clinical and radiologic response. A second surgery with extensive sampling of tissues from the abdomen and pelvis confirmed a complete response to systemic chemotherapy. At four years from onset of disease the patient has no evidence of recurrence.
Conclusions:
Peritoneal metastases from malignant degeneration of ectopic gastric epithelium in a Meckel's diverticulum was reported. Multidisciplinary treatments were beneficial.
Insights
This case study details a rare instance of adenocarcinoma in a Meckel's diverticulum. Multidisciplinary treatment, including chemotherapy, led to a complete response and no recurrence in a patient with peritoneal metastases.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Medical Oncology
Background:
- Meckel's diverticulum is a common congenital gastrointestinal anomaly.
- Ectopic gastric or pancreatic tissue within the diverticulum can undergo malignant transformation.
- Adenocarcinoma arising from Meckel's diverticulum is exceptionally rare.
Purpose of the Study:
- To report a case of peritoneal metastases from adenocarcinoma in a Meckel's diverticulum.
- To describe the multidisciplinary treatment approach and outcomes.
Main Methods:
- Diagnosis confirmed via surgical resection of the affected small bowel segment.
- Systemic chemotherapy administered using a multiagent regimen (oxaliplatin, mitomycin C, doxorubicin, capecitabine - O-Max).
- Second-look surgery performed to assess response to chemotherapy.
Main Results:
- The patient presented with acute abdominal pain and peritoneal metastases.
- The O-Max chemotherapy regimen achieved significant clinical and radiologic response.
- Extensive tissue sampling after chemotherapy confirmed a complete response with no evidence of recurrence at four years.
Conclusions:
- Peritoneal metastases from malignant degeneration of ectopic gastric epithelium in Meckel's diverticulum can be successfully treated.
- A multidisciplinary treatment strategy, including systemic chemotherapy, is beneficial for managing this rare condition.
Related Concept Videos
Esophageal Perforation-I: Introduction
The location of esophageal perforation can vary, occurring anywhere along the esophagus.
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Peptic Ulcer
Gastritis II: Pathophysiology
Pyloric Obstruction
Diverticular Disease of the Colon

